Adana A.M. Llanos, PhD, MPH, discusses how to recognize social determinants of disparities in cancer care.
Adana A.M. Llanos, PhD, MPH, cancer and molecular epidemiologist, Mailman School of Public Health, Columbia University, adjunct associate professor, Rutgers School of Public Health member, American Association for Cancer Research, member, American Public Health Association, member, American Society of Preventive Oncology, member, American Society of Clinical Oncology, member, African-Caribbean Cancer Consortium, discusses how to recognize social determinants of disparities in cancer care.
Although the biology and genetics do play a role with disparities in cancer care, it is important to recognize that social and structural determinants also factor into cancer screening, detections, treatment, and outcomes across different types of cancer, Llanos explains.
Focusing on the various time points throughout this continuum will help achieve more health equity and more equitable outcomes for a greater proportion of patients, Llanos adds. Addressing these disparities needs to be a major goal of long-term research in cancer, Llanos concludes.
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
Dr Gomez Arteaga on an Investigation of Orca-T Vs PTCy-Based HCT in Acute Leukemia and MDS
Dr Banerjee on Nivolumab Use After CAR T-Cell Therapy Progression in Myeloma and NHL
Dr Bertaina on T-allo10 Infusion in Young Patients With Hematologic Malignancies